Mania: diagnosis and treatment recommendations
- PMID: 22986995
- DOI: 10.1007/s11920-012-0324-5
Mania: diagnosis and treatment recommendations
Abstract
This article provides recommendations for the diagnosis and treatment of mania, which characterizes bipolar I disorder (BD I). Failure to detect mania leads to misdiagnosis and suboptimal treatment. To diagnose mania, clinicians should include a detailed mood history within their assessment of patients presenting with depression, agitation, psychosis or insomnia. With regards to treatment, by synthesizing the findings from recent treatment guidelines, and reviewing relevant literature, this paper has distilled recommendations for both acute and long-term management. Antimanic agents including atypical antipsychotics and traditional mood stabilizers are employed to reduce acute manic symptoms, augmented by benzodiazepines if needed, and in refractory or severe cases with behavioural and/or psychotic disturbance, electroconvulsive therapy may occasionally be necessary. Maintenance/prophylaxis therapy aims to reduce recurrences/relapse, for which the combination of psychological interventions with pharmacotherapy is beneficial as it ensures adherence and monitoring of tolerability.
Similar articles
-
[Antipsychotics in bipolar disorders].Encephale. 2004 Sep-Oct;30(5):417-24. doi: 10.1016/s0013-7006(04)95456-5. Encephale. 2004. PMID: 15627046 Review. French.
-
[Treatment of manic phases of bipolar disorder: critical synthesis of international guidelines].Encephale. 2014 Sep;40(4):330-7. doi: 10.1016/j.encep.2013.10.007. Epub 2014 Feb 7. Encephale. 2014. PMID: 24513018 Review. French.
-
Acute and maintenance treatment of bipolar mania: the role of atypical antipsychotics.Bipolar Disord. 2003;5 Suppl 2:7-19. doi: 10.1111/j.1399-2406.2003.00060.x. Bipolar Disord. 2003. PMID: 14700009 Review.
-
Use of antipsychotic drugs and lithium in mania.Br J Psychiatry Suppl. 2001 Jun;41:s148-56. Br J Psychiatry Suppl. 2001. PMID: 11450176 Review.
-
Treating mixed mania/hypomania: a review and synthesis of the evidence.CNS Spectr. 2017 Apr;22(2):177-185. doi: 10.1017/S1092852916000845. Epub 2016 Dec 22. CNS Spectr. 2017. PMID: 28004626 Review.
Cited by
-
Effect of adjunctive benzodiazepines on clinical outcomes in lithium- or quetiapine-treated outpatients with bipolar I or II disorder: results from the Bipolar CHOICE trial.J Affect Disord. 2014 Jun;161:30-5. doi: 10.1016/j.jad.2014.02.046. Epub 2014 Mar 13. J Affect Disord. 2014. PMID: 24751304 Free PMC article. Clinical Trial.
-
Treatment of Bipolar Disorder in a Lifetime Perspective: Is Lithium Still the Best Choice?Clin Drug Investig. 2017 Aug;37(8):713-727. doi: 10.1007/s40261-017-0531-2. Clin Drug Investig. 2017. PMID: 28477315 Review.
-
Towards the clinical implementation of pharmacogenetics in bipolar disorder.BMC Med. 2014 May 30;12:90. doi: 10.1186/1741-7015-12-90. BMC Med. 2014. PMID: 24885933 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical